Nobilis Therapeutics, a biotechnology company specializing in clinical development involving medical inventions which are noble-gas based filed a patent involving its proprietary drug NDTX-001. The drug is expected to inhibit neuroinflammation. [More]
General Motors has secured an Indian patent on a hybrid powertrain control system for vehicles. The patent rights are currently assigned...
Taking into consideration the Delhi High court’s order staying the abandonment orders passed by the Trademarks Office, the Registrar of...
The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of...
Comentários